Calculating clinical progression rates in Parkinson's disease: Methods matter

Progression rates calculated from cross-sectional data not only overestimate actual progression, but also yield a different rank order. We also discuss potential explanations for the discrepancy between both methods and argue that the method of calculating progression rates in data from cross-sectional studies in PD should not be used.